A

Anixa Biosciences

ANIX

3.37000
USD
0.04
(1.20%)
Market Open
Volume
426
EPS
0
Div Yield
0
P/E
-9
Market Cap
118,420,531
Related Instruments
A
AKBA
-0.10000
(-7.25%)
1.28000 USD
A
AXDX
-0.04000
(-2.96%)
1.31000 USD
G
GLMD
-0.00350
(-1.12%)
0.31000 USD
R
RGLS
-0.09000
(-5.06%)
1.69000 USD
News

Title: Anixa Biosciences

Sector: Healthcare
Industry: Biotechnology
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.